secwatch / observer
AVAI AVAI BIO, INC.
CIK 0001740797 34 ready 8-Ks latest May 8, 2026, 7:59 PM ET RSS · JSON
Activity: NORMAL 0 filings / 30d vs 0 baseline
Ready 8-Ks 34
Latest filing May 8, 2026, 7:59 PM ET
Top materiality 0.75
Event mix other_material ×14 · leadership ×11 · m_and_a ×6
Sentiment 0 pos · 2 neg · 32 neu
Executive change recent →

Recent 8-K filings for AVAI

Executive changes

Departed

William Hisey

Chief Financial Officer
AVAI · AVAI BIO, INC.
Effective
2024-09-09
Successor
Vitalis Racius
Filed
September 10, 2024, 7:59 PM ET
Effective September 9, 2024, Mr. Hisey vacated his position as Chief Financial Officer (the “CFO”) of the Company.
Appointed

Vitalis Racius

Chief Financial Officer
AVAI · AVAI BIO, INC.
Effective
2024-09-09
Filed
September 10, 2024, 7:59 PM ET
Mr. Racius, the current Chief Operating Officer (the “COO”), Director, and Treasurer, was reappointed as the Company's Chief Financial Officer (the “CFO”) while continuing his roles as Director and Treasurer.
Role change

Hisey

Chief Financial Officer
AVAI · AVAI BIO, INC.
Effective
2024-07-10
Filed
July 15, 2024, 7:59 PM ET
Mr. Hisey, the current interim CEO of the Company, was reappointed as Chief Financial Officer (the “CFO”).
Role change

Racius

Chief Operating Officer
AVAI · AVAI BIO, INC.
Effective
2024-07-10
Filed
July 15, 2024, 7:59 PM ET
Mr. Racius, the current CFO, Director, and Treasurer, was reappointed as the Company's Chief Operating Officer (the “COO”) while continuing his roles as Director and Treasurer.
Departed

Timothy Lantz

Director
AVAI · AVAI BIO, INC.
Effective
2024-04-24
Filed
April 26, 2024, 7:59 PM ET
Effective April 24, 2024, Mr. Lantz vacated his positions as CEO and Director of the Company.
Departed

Jared Pelski

Vice President – Business Development
AVAI · AVAI BIO, INC.
Effective
2024-04-24
Filed
April 26, 2024, 7:59 PM ET
Effective April 24, 2024, Jared Pelski resigned as Vice President – Business Development of the Company.
Departed

Timothy Lantz

Chief Executive Officer
AVAI · AVAI BIO, INC.
Effective
2024-04-24
Successor
William Hisey
Filed
April 26, 2024, 7:59 PM ET
Effective April 24, 2024, Mr. Lantz vacated his positions as CEO and Director of the Company.
Appointed (interim)

William Hisey

Interim Chief Executive Officer
AVAI · AVAI BIO, INC.
Effective
2024-04-25
Filed
April 26, 2024, 7:59 PM ET
William Hisey – Interim CEO Appointment: On April 24, 2024, Avant Technologies, Inc. (the 'Company') and William Hisey entered into an Employment Agreement pursuant to which Mr. Hisey was retained as Interim Chief Executive Officer ('CEO').
Departed

Angela Harris

Chief Operating Officer
AVAI · AVAI BIO, INC.
Effective
2024-04-24
Filed
April 26, 2024, 7:59 PM ET
Effective April 24, 2024, Angela Harris resigned as Chief Operating Officer ('COO') of the Company.
Appointed

Angela Harris

Chief Operating Officer
AVAI · AVAI BIO, INC.
Effective
2024-02-01
Filed
January 31, 2024, 6:59 PM ET
Angela Harris will undertake the responsibilities of COO, starting February 1, 2024
Appointed

Jared Pelski

Vice President – Business Development
AVAI · AVAI BIO, INC.
Effective
2024-01-17
Filed
January 19, 2024, 6:59 PM ET
Mr. Pelski assumed the role of Vice President – Business Development at the Company on January 17, 2024.
Appointed

Timothy Lantz

Director and Chief Executive Officer
AVAI · AVAI BIO, INC.
Effective
2023-11-03
Filed
November 8, 2023, 6:59 PM ET
On November 3, 2023, Avant Technologies Inc. (the “Company”) and Timothy Lantz entered into an Employment Agreement pursuant to which Mr. Lantz was retained as Director and Chief Executive Officer (“CEO”).

Materiality & sentiment trend

Max materiality 0.75 · Median 0.55 · Most common event other_material

0 positive 2 negative 32 neutral

source · AVAI on sec.gov